CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 113 filers reported holding CALITHERA BIOSCIENCES INC in Q4 2017. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $7,000 | -56.2% | 3,267 | -51.9% | 0.00% | – |
Q1 2021 | $16,000 | +220.0% | 6,794 | +596.1% | 0.00% | – |
Q4 2020 | $5,000 | +400.0% | 976 | +597.1% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 140 | -40.7% | 0.00% | – |
Q1 2020 | $1,000 | -95.7% | 236 | -94.4% | 0.00% | – |
Q4 2019 | $23,000 | +666.7% | 4,178 | +365.8% | 0.00% | – |
Q3 2019 | $3,000 | -62.5% | 897 | -54.6% | 0.00% | – |
Q2 2019 | $8,000 | – | 1,975 | +3850.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 50 | -92.6% | 0.00% | – |
Q3 2018 | $4,000 | -69.2% | 679 | -74.8% | 0.00% | – |
Q2 2018 | $13,000 | -67.5% | 2,694 | -58.0% | 0.00% | – |
Q1 2018 | $40,000 | +1233.3% | 6,411 | +1928.8% | 0.00% | – |
Q4 2017 | $3,000 | -93.9% | 316 | -90.0% | 0.00% | – |
Q3 2017 | $49,000 | +2350.0% | 3,159 | +2275.2% | 0.00% | – |
Q2 2017 | $2,000 | – | 133 | +2116.7% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 6 | -98.5% | 0.00% | – |
Q3 2015 | $2,000 | -60.0% | 412 | -36.4% | 0.00% | – |
Q2 2015 | $5,000 | – | 648 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,072,000 | 4.00% |
BVF INC/IL | 7,299,331 | $15,256,000 | 0.57% |
TSP Capital Management Group, LLC | 463,500 | $969,000 | 0.32% |
Tibra Equities Europe Ltd | 158,500 | $331,000 | 0.10% |
Parkman Healthcare Partners LLC | 100,628 | $210,000 | 0.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 31,382 | $66,000 | 0.03% |
FEDERATED HERMES, INC. | 6,668,978 | $13,938,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 108,111 | $226,000 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 133,580 | $279,000 | 0.02% |
XTX Topco Ltd | 31,242 | $65,000 | 0.02% |